期刊文献+

COX-2抑制剂对膀胱癌细胞株裸鼠成瘤的影响 被引量:2

Inhibitive effect of COX-2 on human bladder cancer cell xenografts in nude mice
下载PDF
导出
摘要 目的探讨COX-2抑制剂对膀胱癌T24细胞株裸鼠成瘤性的影响。方法 BALB/c裸鼠27只分为3组,每只皮下接种膀胱癌T24细胞5×106活细胞数建立移植瘤动物模型。COX-2抑制剂药物干预组(吲哚美辛、塞来昔布)采用喂饲途径,吲哚美辛3mg/kg,塞来昔布10mg/kg;对照组给予生理盐水溶液药物的投给。30d后处死裸鼠,取瘤块称重,测量肿瘤体积,行免疫组化、半定量RT-PCR、Wester Blot检测移植瘤COX-2表达。结果对照组细胞接种裸鼠后第5天可见肿瘤长出,第7天各组均有肿瘤长出,第30天后用药组移植瘤生长较对照组明显减慢。免疫组化染色、RT-PCR、Western-blot结果均显示对照组COX-2表达明显,而药物干预组均少量表达。结论选择性与非选择性COX-2抑制剂在实验中表现出良好的抗肿瘤特性。 ObjectiveTo establish the nude mice xenograft models of bladder cancer cell T24 and to study the inhibitive effects of Cyclooxygenase2 (COX2). Methods Each of 27 athymic BALB/c mice was injected with 5×106 T24 bladder cancer cells. The mice were then divided equally into three groups. One group received oral indomethacin 3 mg/kg per mouse daily, the other 10 mg/kg celecoxib per mouse daily, and the control group received normal saline. The nude mice were killed after 30 days, and the weight and volume of xenografts were recorded. Histological hematoxylinosin staining and immunocytochemical SABC technique were employed to explore the histopathological changes. The expression of COX2 in the xenografts was detected by RTPCR and Westernblot. Results On the 5th day after transplantation, xenografts were found in the control group. On the 7th day, xenografts were observed in the other two groups. The expression level of COX2 reduced and the weight and volume of the xenografts decreased more in the groups treated with indomethacin or celecoxib.Conclusions Selective and nonselective COX2 inhibitors can inhibit the growth of xenografts in nude mice.
出处 《现代泌尿外科杂志》 CAS 2013年第5期453-456,共4页 Journal of Modern Urology
基金 重庆市卫生局面上项目(No.06-2-061)
关键词 环氧化酶-2 膀胱肿瘤 塞来昔布 吲哚美辛 cyclooxygenase-2 bladder cancer celecoxib indomethacin
  • 相关文献

参考文献16

  • 1JEMALI A, SIEGEL R, XU J, et al. Cancer statistics [J]. Cancer J Clinicians,2010,60(5) 277-300. 被引量:1
  • 2PASIN E, JOSEPHSON DY, MITRA AP, et al. Superficial bladder cancer: an update on etiology, molecular development, classification, and natural history [J]. Rev Urol,2008, 10:31- 43. 被引量:1
  • 3PARADA B, SERENO J, REIS F, et al. Anti-inflammatory, anti-proliferative and antioxidant profiles of selective cyclooxyge- nase-2 inhibition as ehemoprevention for rat bladder carcinogene- sis[J]. Cancer Biol Ther,2009,8:1615-1622. 被引量:1
  • 4OKAMOTO A, SHIRAKAWA T, BITO T, et al. Etodolac, a selective cyclooxygenase-2 inhibitor, induces upregulation of E- cadherin and has antitumor effect on human bladder cancer cell- sin vitroandin vivo [J]. Urology, 2008,71 : 156-160. 被引量:1
  • 5DHAWA ND, CRAIG BA, CHENG L, et al. Effects of short- term eelecoxib treatment in patients with invasive ransitional cell carcinoma of the urinary bladder [J]. Mol Cancer Ther,2010,9: 1371-1377. 被引量:1
  • 6SOORIAKUMARAN P, MACANAS-PIRARD P, BUCCA G, et al. A gene expression profiling approach assessing celecoxih in a randomized controlled trial in prostate cancer [J]. Cancer Gen Proteomics, 2009,6 : 93-99. 被引量:1
  • 7CHAN AT, OGINO S, FUCHS CS. Aspirin and the risk of colorectal cancer in relation to the expression of COX-2 [J]. New Engl J Med, 2007,356(21) :2131-2142. 被引量:1
  • 8FLOSSMANN E, ROTHWELL PM. Effect of aspirin on long- term risk of colorectal cancer:consistent evidence from random- ised and observational studies[J]. The Lancet, 2007,369 1603 1613. 被引量:1
  • 9MARGULIS V, SHARIAT SF, ASHFAQ R, et al. Expression of cyclooxygenase-2 in normal urothelium, and superficial and advanced transitional cell carcinoma of bladder [J]. J Urology, 2007,177(3) 1163-1168. 被引量:1
  • 10王春荣,林宗明,陈耀武.COX-2抑制剂对膀胱肿瘤的抑制作用[J].现代泌尿外科杂志,2009,14(2):110-113. 被引量:5

二级参考文献9

  • 1武文森,尹克铮,韩月明,张晓明,张东生,洪大落.小鼠可移植性膀胱移行细胞癌株(BTT739)的建立及实验研究[J].中国肿瘤临床,1996,23(10):751-756. 被引量:23
  • 2TAMURA M, SEBASTIAN S, GURATES B, et al. Vascular endothelial growth factor up-regulates cyclooxygenase-2 expression in human endothelial cells [J]. J Clin Endocrinol Metab, 2002, 87(7) : 3504-3507. 被引量:1
  • 3AKARASEREENONT PC, TECHATRAISAK K, THAWORN A, et al. The expression of COX-2 in VEGF-treated endothelial cells is mediated through protein tyrosine kinase [J]. Mediators Inflamm, 2002, 11(1):17-22. 被引量:1
  • 4THUN MJ, NAMBOODIRI MM, CALLE EE, et al. Aspirin use and risk of fatal cancer [J]. Cancer Res, 1993, 53(6): 1322- 1327. 被引量:1
  • 5MOHAMMED SI, KNAPP DW, BOSTWICK DG, et al. Expression of cyclooxygenase-2 (COX-2) in human invasive transitional cell carcinoma (TCC) of the urinary bladder [J]. Cancer Res, 1999, 59:5647-5650. 被引量:1
  • 6MARGULIS V, SHARIAT SF, ASHFAQ R, et al. Expression of cyclooxygenase-2 in normal urothelium, and superficial and advanced transitional cell carcinoma of bladder [J]. J Urol, 2007, 177(3):1163-1168. 被引量:1
  • 7WANG L, CHEN W, XIE X, et al. Celecoxib inhibits tumor growth and angiogenesis in an orthotopic implantation tumor model of human colon cancer [J]. Exp Oncol, 2008, 30(1):42-51. 被引量:1
  • 8EIBL G, BRUEMMER D, OKADA Y, et al. PGE2 is generated by specific COX-2 activity and increases VEGF production in COX-2-expressing human pancreatic cancer cells[J]. Biochem Biophys Res Commun, 2003, 106(4) :887-897. 被引量:1
  • 9刘洁,庄乾元,余沁楠,窦启锋,张英杰.survivin和环氧化酶-2在膀胱移行细胞癌组织中的表达及其相关性[J].现代泌尿外科杂志,2008,13(2):117-120. 被引量:2

共引文献4

同被引文献23

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部